Harbour Investments’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Harbour Investments’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50	Closed	-$1.26K	–	3050
2022 Q4	$1.26K	Sell	50 -258	-84%	-$6.93K	﹤0.01%	2639
2022 Q3	$9K	Hold	308	–	–	﹤0.01%	1970
2022 Q2	$9K	Buy	+308	New	+$9.19K	﹤0.01%	1970
2021 Q4	$16K	Sell	368 -150	-29%	-$7.1K	﹤0.01%	1754
2021 Q3	$26K	Hold	518	–	–	﹤0.01%	2154
2021 Q2	$27K	Hold	518	–	–	﹤0.01%	2164
2021 Q1	$24K	Buy	+518	New	+$25.3K	﹤0.01%	2111

Other funds holding IDNA

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Harbour Investments's IDNA Position: Q1 2023 in Review

Harbour Investments sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2023, closing a stake of 50 shares — an estimated $1.26K sold.

Harbour Investments first reported a position in IDNA in Q1 2021 and held it in 7 quarters. The position peaked at $27K in Q2 2021. 75 funds tracked by Wall St. Rank hold IDNA as of Q1 2023.

Harbour Investments reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2023 after selling out during the quarter.
Harbour Investments sold 50 iShares Genomics Immunology and Healthcare ETF shares in Q1 2023, an estimated $1.26K.
Harbour Investments first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2021 and held it in 7 quarters.
Harbour Investments's iShares Genomics Immunology and Healthcare ETF position peaked at $27K in Q2 2021.
75 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2023.

Based on Harbour Investments's 13F filing for Q1 2023, filed 15 May 2023.